Drug-induced ciliary body oedema: A new theory

Eye

Volumn 10, Issue 1, 1996, Pages 121-126

  Krieg, Peter H ^a,b   Schipper, Isaac ^a  

^a LUZERNER KANTONSSPITAL   (Switzerland)

^b NONE   (Switzerland)

Author keywords

Aspirin sensitive asthma; Ciliary body oedema; Drug reaction; Leucotrienes; Prostaglandins; Transient myopia

Indexed keywords

ACETAZOLAMIDE; CHLORTALIDONE; DIPIVEFRINE; ICOSANOID; LEUKOTRIENE; PILOCARPINE; PROSTAGLANDIN; SULFONAMIDE;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CILIARY BODY; EDEMA; FEMALE; HUMAN; MALE; MYOPIA; PREGNANCY;

EID: 0029867205     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1996.21     Document Type: Article

References (59)

1. Ericson LA. Hygroton-induced myopia and retinal edema. Acta Ophthalmol (Copenh) 1963;41:538-43.
2. Michaelson JJ. Transient myopia due to Hygroton. Am J Ophthalmol 1962;54:1146-7.
3. Chirls AI, Norris JW. Transient myopia associated with vaginal sulfanilamide suppositories. Am J Ophthalmol 1984;98:120-1.
4. Boissonnot L, Boissonnot M, Charles-Gervais C, Breux JP. Myopie aiguë due à lindapamide. Presse Med 1986;15:802-3.
5. Back M. Transient myopia after the use of acetazolamide (Diamox). Arch Ophthalmol 1956;55:546-7.
6. Murihead JF, Scheie HG. Transient myopia after acetazolamide. Arch Ophthalmol 1960;63:315-8.
7. Fan JT, Johnson DH, Burk RR. Transient myopia, angle-closure glaucoma and choroidal detachment after oral acetazolamide. Am J Ophthalmol 1993; 115:813-4.
8. Bovino JA, Marcus DF. The mechanism of transient myopia induced by sulfonamide therapy. Am J Ophthalmol 1982;94:99-102.
9. Teller J, Rasin M, Abraham FA. Accommodation insufficiency induced by glibenclamide. Ann Ophthalmol 1989;21:275-6.
10. Bard LA. Transient myopia associated with promethazine (Phenergane) therapy. Am J Ophthalmol 1964; 58:682-6.
11. Belci C. Myopia transitoria in caso di terapia con diuretici. Boll Ocul 1968;47:24-31.
12. Stern J. Transient myopia in a case of dermatitis treated with ACTH. Arch Ophthalmol 1956;54:762.
13. Dangel ME, Weber PA, Leier CB. Transient myopia following isosorbide dinitrate. Ann Ophthalmol 1983; 15:1156-8.
14. Manor R, Dickermann Z, Llaron Z. Myopia during bromocriptine treatment. Lancet 1981;1:102.
15. Edwards TS. Transient myopia due to tetracycline. JAMA 1963;186:69-70.
16. Michiels J, Laterre C, Dumoulin D. Les manifestations oculaires de la maladie de Wilson traitée à la penicillinamine. Bull Soc Belge Ophtalmol 1962; 132:552-61.
17. Segal A, Aisemberg A, Ducass A. Quinine, myopie transitoire et glaucome par fermeture de l'angle. Bull Soc Ophtalmol Fr 1983;83:247-9.
18. Grinbaum A, Ashkenazi I, Avni I, Blumenthal M. Transient myopia following Metronidazole treatment for Trichomonas vaginalis. JAMA 1992;267:511-2.
19. Palestine AG. Transient acute myopia resulting from isoretinoin (Accutane) therapy. Ann Ophthalmol 1984;16:660-2.
20. Sandford-Smith JH. Transient myopia after aspirin. Br J Ophthalmol 1974;58:698-700.
21. Beasley FJ. Transient myopia and retinal edema during hydrochlorothiazide (Hydrodiuril) therapy. Arch Ophthalmol 1961;65:212-3.
22. Maddalena M. Transient myopia associated with acute glaucoma and retinal edema. Arch Ophthalmol 1968; 80:186-8.
23. Ryan EH, Jampol LM. Drug-induced acute transient myopia with retinal folds. Retina 1986;6:220-3.
24. Solomon LM, Juhlin L, Kirschbaum MB. Prostaglandins on cutaneous vasculature. J Invest Dermatol 1968:51:280.
25. Tso MOM, Skik CY. Experimental macular edema after lens extraction. Invest Ophthalmol Vis Sci 1977; 16:381-92.
26. Ambache N. Irin, a smooth-muscle contracting substance present in rabbit iris. J Physiol (Lond) 1955;129:65-6.
27. Waitzman MB, King CD. Prostaglandin influences on intraocular pressure and pupil size. Am J Physiol 1967;212:329-37.
28. Camras CB, Bito LZ, Eakins KE. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Invest Ophthalmol Vis Sci 1977;16:1125-34.
29. 2 restores furosemide response in indomethacin-treated rats. Am J Physiol 1986;250:F980-5.
30. Le Bel M, Grose JH, Belleau LJ, Langlois S. Anti-hypertensive effects of indapamide with special emphasis on renal prostaglandin production. Cur Med Res Opin 1983;8(Suppl 3):81-6.
31. Webster J, Dollery CT, Hensby CN. Circulating prostacyclin levels may be increased by bendrofluazide in patients with essential hypertension. Clin Sci Mol Med 1980;59:125-8s.
32. O'Donnell WJ, Rosenberg M, Niven RW, Drazen JM, Israel E. Acetazolamide and furosemide attenuate asthma induced by hyperventilation of cold, dry air. Am Rev Respir Dis 1992;146:1518-23.
33. Lewis PJ, Boylan P, Friedmann LA, Hensby CN, Downing I. Prostacyclin in pregnancy. BMJ 1980; 280:1581-2.
34. Moncada S, Ferreira SH, Vane JR. Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature 1973;246:217-9.
35. Wiliams TJ, Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 1973;246:215-7.
36. Eakins KE. Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier. Exp Eye Res 1977;Suppl:483-98.
37. Doenicke A, Schoning B. The role of histamine in adverse reactions to intravenous agents. In: Thornton JA, editor. Adverse reactions of anaesthetic drugs. Amsterdam: Elsevier/North Holland, 1981:169-238.
38. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ 1975;1:67-9.
39. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568-75.
40. Murphy RC, Hammarstrom S, Samuelson B. Leukotriene C, a slow reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 1979;76:4275-9.
41. Morris HR, Taylor GW, Piper PJ, Tippins JR. Structure of slow-reacting substance of anaphylaxis from guinea pig lung. Nature 1980;285:104-5.
42. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9.
43. Lee TH. Mechanism of aspirin sensitivity. Am Rev Respir Dis 1992;145:34-6.
44. 4 release from activated neutrophils. Proc Natl Acad Sci USA 1983;80:4349-59.
45. Soifer SJ, Schreiber MD, Heymann MA. Leukotriene antagonists attenuate thromboxane-inducible pulmonary hypertension. Pediatr Res 1989;26:83-7.
46. 4) secretion from monocytes of aspirin (ASA) sensitive asthmatic patients. J Allergy Clin Immunol 1991;87:221.
47. Parker JA, Goetzl EJ, Friedlander MH. Leukotrienes in the aqueous humor of patients with uveitis. Arch Ophthalmol 1986;104:722-4.
48. Bhattacherjee P, Hammond B, Salmon JA, Eakins KE. Effect of lipoxygenase products on leukocyte accumulation in the rabbit eye. Adv Prostaglandin Thromboxane Leukotriene Res 1982;9:325-30.
49. 4 in the cat. Prostaglandins 1984;27:5-15.
50. 4 in rabbit and human eyes. Invest Ophthalmol Vis Sci 1985; 26(Suppl):191.
51. Bito LZ, Salvador EV. Intraocular fluid dynamics. III. The site and mechanism of prostaglandin transfer across the blood-intraocular fluid barriers. Exp Eye Res 1972;14:233-41.
52. Miyake K, Shirasawa E, Hikita M. Active transport system of prostaglandins: clinical implications and considerations. J Cataract Refract Surg 1992;18:100-5.
53. Engstrom P, Dunham EW. Alpha-adrenergic stimulation of prostaglandin release from rabbit iris-ciliary body in vitro. Invest Ophthalmol Vis Sci 1982; 22:757-67.
54. Goyal RK. Muscarinic receptor subtypes: physiology and clinical implications. N Engl J Med 1989; 321:1022-9.
55. Reichmann M, Nen W, Hokin LE. Highly sensitive muscarinic receptors in the cerebellum are coupled to prostaglandin formation. Biochem Biophys Res Commun 1987;146:1256-61.
56. McGiff LC, Crowshaw K, Terragno NA, Lonigro AJ. Release of prostaglandin-like substance into renal venous blood in response to angiotensin II. Circ Res 1970;26/27:I121-30.
57. Peach MJ, Loeb AL, Singer HA, Saye J. Endothelium-derived vascular relaxing factor. Hypertension 1985;7 (Suppl I):94-100.
58. 4) receptor antagonist (MK 571) in patients with asthma. Am Rev Respir Dis 1992;146:358-63.
59. Christie PE, Smith CM, Lee TH. The potent and selective sulfidopeptide leukotriene antagonist SK & F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis 1991;144:957-8.